Heart Failure: Living with a Hurting Heart. Congestive Heart Failure Heart (or cardiac) failure is the state in which the heart is unable to pump blood.

Slides:



Advertisements
Similar presentations
Research By: Dr. Ritta Baena Visual Effects By: John Baena
Advertisements

Advanced Heart Failure and the Role of Mechanical Circulatory Support
Congestive Heart Failure
Congestive heart failure guideline. Functional classification( NYHA) Class IV: symptoms at rest Class III: symptoms on less-than-ordinary exertion Class.
Congestive heart failure
Implantable Cardioverter Defibrillator Rebecca Boduch Biomedical Engineering University of Rhode Island.
Prepared by : Nehad J. Ahmed.  Heart failure, also known as congestive heart failure (CHF), means your heart can't pump enough blood to meet your body's.
© 2000 Heart Failure Society of America, Inc.
The Heart and Heart Failure in the Year 2013 Jonathan D. Rich, MD Associate Director, Mechanical Circulatory Support Program Bluhm Cardiovascular Institute.
ICD FOR PRIMARY PREVENTION EVIDENCE REVIEW
E LECTROCARDIOGRAM AND THE D IAGNOSIS OF C ONGESTIVE H EART F AILURE By Angela Thomas.
Sudden Cardiac Death in Heart Failure Trial Presented at American College of Cardiology Scientific Sessions 2004 Presented by Dr. Gust H. Bardy SCD-HeFTSCD-HeFT.
Dean Handimulya UIEU 2005 Congestive Heart Failure Dean Handimulya, M.D.
Canadian Diabetes Association Clinical Practice Guidelines Treatment of Diabetes in People with Heart Failure Chapter 28 Jonathan G. Howlett, John C. MacFadyen.
Heart disease. Congenital Ischemic Hypertensive Valvular Cardiomyopathy Pericardium Tumors.
Pharmacologic Treatment of Chronic Systolic Heart Failure John N. Hamaty D.O. FACC, FACOI.
Congestive Heart Failure. What is it? The inability of the heart to supply steady blood flow to meet the bodies needs.
Mr. J is a 70 year old man with an ischemic cardiomyopathy who presents with class III CHF and significant dissatisfaction with his functional capacity.
Drugs for CCF Heart failure is the progressive inability of the heart to supply adequate blood flow to vital organs. It is classically accompanied by significant.
Heart Failure Daniel E. van Buren, M.D. New England Heart Institute
Update on  -Blockers In the Management of Heart Failure.
Heart Failure Ben Starnes MD FACC Interventional Cardiology
Lifestyles, Fitness and Rehabilitation Heart Failure.
Appendix: Clinical Guidelines VBWG. I Intervention is useful and effective III Intervention is not useful or effective and may be harmful A Data derived.
HEART FAILURE Prevalence increasing in our ageing population Incidence doubles with each decade between 40 and 80 At any age more common in men than women.
2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults p.o.box zip code Done by: Dr.Amin Zagzoog.
Gilead -Topics in Human Pathophysiology Fall 2010 Drug Safety and Public Health.
Treatment of Heart Failure: Beyond Medical Therapy
Congestive Heart Failure!!. Question 1 What’s a symptom of congestive heart failure?? A. shortness of breath B. chest pain C. No appetite D. all of the.
Current Management of Heart Failure GP clinical update 17 th June 2015 Dr Raj Bilku Consultant Cardiologist Clinical Lead Cardiology QEH.
Heart Failure Management Applying the ACC/AHA Chronic Heart Failure Guidelines David Bragin Sánchez MD FACC Cardiomyopathy and Cardiac Transplant Specialist.
Medical Progress: Heart Failure. Primary Targets of Treatment in Heart Failure. Treatment options for patients with heart failure affect the pathophysiological.
Heart Failure (HF) : Overview Common underlying heart diseases or causes of HF 1.Valvular HD-Rheumatic etiology 2.Cardiomyopathy – Dilated type 3.Ischemic.
To know more visit HeartFailure.com © 2015 Novartis Pharma AG, May 2015, GLCM/HTF/0028 HEART FAILURE DISEASE MANAGEMENT STANDARDS.
Outpatient Heart Failure Management Common Problems Elaine Winkel, M.D. University of Wisconsin Heart Failure and Transplant Program.
Heart failure: The national burden AHA. Heart disease and stroke statistics–2005 update. Koelling TM et al. Am Heart J. 2004;147:74-8. VBWG Affects 1 million.
IRIS Post-hoc Analysis Background IRIS compared the safety and efficacy of early ICD implantation with medical treatment alone in 898 patients at high.
Heart disease. Congenital Ischemic Hypertensive Valvular Cardiomyopathy Pericardium Tumors.
Bell Ringer What are Three adaptations for the fetal circulations?
Heart Failure: ACC Guidelines for Dx and Management Steven W. Harris MHS PAC.
Heart Failure Devices: Staying Connected Lisa D. Rathman, MSN, CRNP, CCRN, CHFN The Heart Group of Lancaster General Health Lancaster, PA.
Internal Medicine Workshop Series Laos September /October 2009
Relationship of background ACEI dose to benefits of candesartan in the CHARM-Added trial.
Heart Failure Cardiac Insufficiency. What is Heart Failure? Heart failure is a progressive disorder in which damage to the heart causes weakening of the.
Heart Failure: medication Types of Heart Failure Systolic (or squeezing) heart failure –Decreased pumping function of the heart, which results in fluid.
PHARMACOLOGIC THERAPY  Standard First-Line Therapies Angiotensin-Converting Enzyme Inhibitors (ACEI) β Blockers Diuretics Digoxin  Second line Therapies.
Date of download: 6/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Quality of Care of and Outcomes for African Americans.
CRT Overview This lecture is intended to give a basic overview of HF to include: -General knowledge of the cardiac cycle and how a normal heart should.
Ridha Chakeer MD PGY3. Objectives: Approximately 5.2 million Americans are affected  accounts for more than 3 million outpatient visits to primary care.
ΠΜΣ Επιστήμες Αποκατάστασης
Heart Failure in Women Dr. Jennifer Haythe
Chronic heart failure By Vishal Patel GPVTS1.
Fig ACCF/AHA Guideline for the management of heart failure
Treatment options for patients with chronic symptomatic systolic heart failure. ACE, angiotensinconvertingenzyme; ARB, angiotensin receptor blocker; CRT-D,
Treatment options for patients with chronic symptomatic systolic heart failure. ACE, angiotens inconverting enzyme; ARB, angiotensin receptor blocker;
Dike Ojji Senior Lecturer
Heart Failure - Summary
Congestive heart failure
Diabetes Mellitus and Heart Failure
Clyde W. Yancy et al. JACC 2017;70:
Ann Parker Cardiology Pharmacist Frimley Health
Step Care Therapy for Hypertension in Diabetic Patients
Section III: Neurohormonal strategies in heart failure
Stepwise treatment of patients with symptomatic (NYHA II–IV) heart failure with reduced ejection fraction. Stepwise treatment of patients with symptomatic.
Fig. 2. Evidence-based medication prescriptions
Shannon M. Dunlay, MD, MS, Naveen L. Pereira, MD, Sudhir S
β-Blocker Use for the Stages of Heart Failure
Stepwise treatment of patients with symptomatic (NYHA II–IV) heart failure with reduced ejection fraction. Stepwise treatment of patients with symptomatic.
Presentation transcript:

Heart Failure: Living with a Hurting Heart

Congestive Heart Failure Heart (or cardiac) failure is the state in which the heart is unable to pump blood at a rate commensurate with the requirements of the tissues or can do so only from high pressures Braunwald 8 th Edition, 2001

Heart Failure Heart A heart failure heart has a reduced ability to pump blood.

CAD=coronary artery disease; LVH=left ventricular hypertrophy. Risk Factors for Heart Failure Coronary artery disease Hypertension (LVH) Valvular heart disease Alcoholism Infection (viral) Diabetes Congenital heart defects Other: –Obesity –Age –Smoking –High or low hematocrit level –Obstructive Sleep Apnea

Classification of HF: Comparison Between ACC/AHA HF Stage and NYHA Functional Class 1 Hunt SA et al. J Am Coll Cardiol. 2001;38:2101– New York Heart Association/Little Brown and Company, Adapted from: Farrell MH et al. JAMA. 2002;287:890–897. ACC/AHA HF Stage 1 NYHA Functional Class 2 AAt high risk for heart failure but without structural heart disease or symptoms of heart failure (eg, patients with hypertension or coronary artery disease) BStructural heart disease but without symptoms of heart failure CStructural heart disease with prior or current symptoms of heart failure DRefractory heart failure requiring specialized interventions I Asymptomatic II Symptomatic with moderate exertion IV Symptomatic at rest III Symptomatic with minimal exertion None

How Heart Failure Is Diagnosed Medical history is taken to reveal symptoms Physical exam is done Tests –Chest X-ray –Blood tests –Electrical tracing of heart (Electrocardiogram or “ECG”) –Ultrasound of heart (Echocardiogram or “Echo”) –X-ray of the inside of blood vessels (Angiogram)

Heart Failure Treatments: Medication Types ACE inhibitor (angiotensin-converting enzyme) ARB (angiotensin receptor blockers) Beta-blocker Digoxin Diuretic Aldosterone blockade Type What it does Expands blood vessels which lowers blood pressure, neurohormonal blockade Similar to ACE inhibitor—lowers blood pressure Reduces the action of stress hormones and slows the heart rate Slows the heart rate and improves the heart’s pumping function (EF) Filters sodium and excess fluid from the blood to reduce the heart’s workload Blocks neurohormal activation and controls volume

Device Therapy: Biventricular Pacing

Overview of Device Therapy9 Biventricular Pacing Ventricular Dysynchrony Abnormal ventricular conduction resulting in a mechanical delay and dysynchronous contraction

BiV Pacing

Cardiac Resynchronization Therapy Key Points Indications –Moderate to severe CHF who have failed optimal medical therapy –EF<30% –Evidence of electrical conduction delay Timing of Referral Important –Patients often not on optimal Medical Rx –Patients referred too late- Not a Bail Out

Defibrillators (ICD’s)

Heart Failure and Sudden Cardiac Death Sudden Cardiac Death (SCD) –Your heart suddenly goes into a very fast and chaotic rhythm and stops pumping blood –Caused by an “electrical” problem in your heart –SCD is one of the leading causes of death in the U.S. – approximately 450,000 deaths a year –Patients with heart failure are 6-9 times as likely to develop sudden cardiac death as the general population

How does a defibrillator for sudden cardiac death work? Device Shown: Combination Pacemaker & Defibrillator

Implantable Cardiac Defribrillators EBM TherapiesRelative Risk Reduction Mortality 2 year ACE-I 23% 27% Β-Blockers 35% 12% Aldosterone Antagonists 30% 19% ICD 31% 8.5%

Who should Consider an ICD? Patients with weakend heart, New York Heart Association (NYHA) Class II and III heart failure, and measured left ventricular ejection fraction (LVEF) < 35% Patients who meet all current requirements for a cardiac resynchronization therapy (CRT) device and have NYHA Class IV heart failure;

Other Therapies? Transplant Artificial hearts New “gadgets” to help doctors manage heart failure

Heart Transplantation A good solution to the failing heart– get a new heart Unfortunately we are limited by supply, not demand Approximately 2200 transplants are performed yearly in the US, and this number has been stable for the past 20 years.

Worldwide Heart Transplants

Newer Generation Artificial Hearts

Future Tech

Intrathoracic Impedance for Heart Failure

One of the Best Devices for Monitoring Heart Failure

What have we learned?

In Summary…. Heart failure is common and has high mortality Drug therapy improves survival –Betablockers, ACE-I, aldosterone antagonists Newer device therapies are showing promise for symptom relief and improved survival –Biventricular pacing, ICD’s Transplants remain rare, but technology for mechanical assist devices continues to improve- stay tuned!